Serpiginous choroiditis

被引:106
作者
Lim, WK
Buggage, RR
Nussenblatt, RB
机构
[1] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA
[2] Singapore Natl Eye Ctr, Singapore, Singapore
关键词
ampiginous choroiditis; geographic choroiditis; geographic choroidopathy; posterior uveitis; relentless placoid chorioretinitis; serpiginous choroiditis; serpiginous choroidopathy; triple therapy;
D O I
10.1016/j.survophthal.2005.02.010
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Serpiginous choroiditis is a rare, usually bilateral, chronic, progressive, recurrent inflammation of the choroid, retinal pigment epithelium, and choriocapillaris of unknown etiology. Based on clinical presentation, it can be classified into 1) peripapillary, 2) macular, and 3) ampiginous types. The clinical course, regardless of the presentation, is progressive with multiple recurrences leading to potentially significant visual loss. Visual outcome is directly related to the involvement of the para-fovea and fovea by the lesions or secondary choroidal neovascularization. The histological findings of the lesions are atrophy of the choriocapillaris, retinal pigment epithelium and photoreceptor cells, and moderate diffuse lymphocytic infiltrates throughout the choroid. Multiple etiologies including autoimmunity, infection, vasculopathy, and degeneration were proposed but none is well supported by clinical and laboratory evidence. Fluorescein and indocyanine green angiography have been useful in the assessment of the extent and the activity of lesions. Due to the insidious and progressive clinical course, an assessment of treatment outcomes needs long term follow-up. Currently, treatment with immunosuppressive and alkylating agents have shown possible efficacy in small case series. Larger clinical studies and interventional trials are required to further our understanding of the pathogenesis, etiology, and for the evaluation of treatment strategies. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:231 / 244
页数:14
相关论文
共 80 条
[1]   SERPIGINOUS (GEOGRAPHICAL) CHOROIDITIS [J].
ABUELASRAR, AM .
INTERNATIONAL OPHTHALMOLOGY CLINICS, 1995, 35 (02) :87-91
[2]   Successful treatment of serpiginous choroiditis with alkylating agents [J].
Akpek, EK ;
Jabs, DA ;
Tessler, HH ;
Joondeph, BC ;
Foster, CS .
OPHTHALMOLOGY, 2002, 109 (08) :1506-1513
[3]   Long-term immunosuppressive treatment of serpiginous choroiditis [J].
Akpek, EK ;
Baltatzis, S ;
Yang, J ;
Foster, CS .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2001, 9 (03) :153-167
[4]  
Akpek Esen Karamursel, 2003, Curr Opin Ophthalmol, V14, P128, DOI 10.1097/00055735-200306000-00003
[5]   Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome [J].
Araujo, AAQ ;
Wells, AP ;
Dick, AD ;
Forrester, JV .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (09) :979-982
[6]   SERPIGINOUS (GEOGRAPHIC) CHOROIDITIS [J].
BAARSMA, GS ;
DEUTMAN, AF .
DOCUMENTA OPHTHALMOLOGICA, 1976, 40 (02) :269-285
[7]  
BABEL J, 1983, J FR OPHTALMOL, V6, P981
[8]  
Bacin F, 1983, Bull Soc Ophtalmol Fr, V83, P1153
[9]  
BECQUET F, 1992, J FR OPHTALMOL, V15, P288
[10]  
Biswas J, 1997, INT OPHTHALMOL, V20, P223, DOI 10.1023/A:1006011114199